Hagens Berman Advises PTC Therapeutics (NASDAQ: PTCT) Investors of May 2, 2016 Lead Plaintiff Deadline in a Newly Filed Class Action
08. März 2016 08:30 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, March 08, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm announces the filing of a securities fraud class action lawsuit against PTC...